An experimental coronavirus vaccine made by Moderna provoked promising immune responses and appeared safe in the first 45 people who received it, researchers reported on Tuesday. Phase 3 tests involving 30,000 people are expected to begin on July 27.
on Wednesday, July 15th, 2020 9:57am
7527 likes, 3932 retweets
mikenov on Twitter